Cardiac Sympathetic Denervation and Ongoing Myocardial Damage for Prognosis in Early Stages of Heart Failure

Journal of Cardiac Failure

Volumn 13, Issue 1, 2007, Pages 34-41

  Arimoto, Takanori ^a   Takeishi, Yasuchika ^a   Niizeki, Takeshi ^a   Nozaki, Naoki ^a   Hirono, Osamu ^a   Watanabe, Tetsu ^a   Nitobe, Joji ^a   Tsunoda, Yuichi ^a   Suzuki, Satoshi ^a   Koyama, Yo ^a   Kitahara, Tatsuro ^a   Okada, Akio ^a   Takahashi, Kazuei ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

123I MIBG imaging; H FABP; Heart failure

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN;

ADULT; AGED; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG UPTAKE; FEMALE; HEART FAILURE; HEART MUSCLE INJURY; HEART SCINTISCANNING; HUMAN; INDEPENDENT VARIABLE; MALE; MEDIASTINUM; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

3-IODOBENZYLGUANIDINE; AGED; FATTY ACID-BINDING PROTEINS; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM;

EID: 33847297962     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.09.002     Document Type: Article

References (32)

1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20 (1992) 248-254
2. Bohm M., La Rosee K., Schwinger R.H., and Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25 (1995) 146-153
3. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676
4. Sisson J.C., Shapiro B., Meyers L., Mallette S., Mangner T.J., Wieland D.M., et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28 (1987) 1625-1636
5. Schofer J., Spielmann R., Schuchert A., Weber K., and Schluter M. Iodine-123 metaiodo-benzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12 (1988) 1252-1258
6. Glowniak J.V., Turner F.E., Gray L.L., Palac R.T., Lagunas-Solar M.C., and Woodward W.R. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 30 (1989) 1182-1191
7. Henderson E.B., Kahn J.K., Corbett J.R., Jansen D.E., Pippin J.J., Kulkarni P., et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78 (1988) 1192-1199
8. Merlet P., Valette H., Dubois-Rande J.L., Moyse D., Duboc D., Dove P., et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33 (1992) 471-477
9. Imamura Y., Ando H., Mitsuoka W., Egashira S., Masaki H., Ashihara T., et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity on congestive heart failure independent of underlying cause. J Am Coll Cardiol 26 (1995) 1594-1599
10. Imamura Y., Ando H., Ashihara T., and Fukuyama T. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload. J Am Coll Cardiol 28 (1996) 371-375
11. Nakata T., Miyamoto K., Doi A., Sasao H., Wakabayashi T., Kobayashi H., et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5 (1998) 579-590
12. Tanaka T., Hirota Y., Sohmiya K., Nishimura S., and Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 24 (1991) 195-201
13. Kleine A.H., Glatz J.F., Van Nieuwenhoven F.A., and Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116 (1992) 155-162
14. Glatz J.F., Klein A.H., van Nieuwenhoven F.A., Hermens W.T., van Dieijen-Visser M.P., and van Vusse G.J. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 71 (1994) 135-140
15. Setsuta K., Seino Y., Ogawa T., Arao M., Miyatake Y., and Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 113 (2002) 717-722
16. Arimoto T., Takeishi Y., Shiga R., Fukui A., Tachibana H., Nozaki N., et al. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 11 (2005) 56-60
17. Niizeki T., Takeishi Y., Arimoto T., Okuyama H., Fukui A., Tachibana H., et al. Risk stratification using a combination of heart-type fatty acid binding protein and brain natriuretic peptide in patients hospitalized for congestive heart failure. Circ J 69 (2005) 922-927
18. Niizeki T., Takeishi Y., Arimoto T., Okuyama H., Takabatake N., Tachibana H., et al. Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure. J Cardiol 46 (2005) 9-15
19. Arimoto T., Takeishi Y., Niizeki T., Koyama Y., Okuyama H., Nozaki N., et al. Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure. Ann Nucl Med 19 (2005) 535-540
20. Arimoto T., Takeishi Y., Niizeki T., Takabatake N., Okuyama H., Fukui A., et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail 11 (2005) 595-601
21. Takeishi Y., Atsumi H., Fujiwara S., Takahashi K., and Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38 (1997) 1085-1089
22. Atsumi H., Takeishi Y., Fujiwara S., and Tomoike H. Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure. Nucl Med Commun 19 (1998) 451-456
23. 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure. Ann Nucl Med 18 (2004) 145-150
24. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
25. Wakabayashi T., Nakata T., Hashimoto A., Yuda S., Tsuchihashi K., Travin M.I., et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 42 (2001) 1757-1767
26. Nakata T., Wakabayashi T., Kyuma M., Takahashi T., Hashimoto A., Ogata H., et al. Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction. J Card Fail 9 (2003) 113-121
27. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., and Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94 (1996) 2837-2842
28. Recchia F.A., McConnell P.I., Bernstein R.D., Vogel T.R., Xu X., and Hintze T.H. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 83 (1998) 969-979
29. Yamauchi S., Takeishi Y., Minamihaba O., Arimoto T., Hirono O., Takahashi H., et al. Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with chronic heart failure. Nucl Med Comm 24 (2003) 901-906
30. Binas B., Danneberg H., McWhir J., Mullins L., and Clark A.J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13 (1999) 805-812
31. Kyuma M., Nakata T., Hashimoto A., Nagao K., Sasao H., Takahashi T., et al. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. J Nucl Med 45 (2004) 155-163
32. Arimoto T., Takeishi Y., Shiga R., Okuyama H., Niizeki T., Fukui A., et al. Prognostic value of elevated circulating levels of heart-type fatty acid binding protein in heart failure patients with preserved left ventricular systolic function. [abstract]. Circulation 110 Suppl. (2004) III-750